Archive for the ‘New drug approbation’ Category

FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder. Drug approbation.

Tuesday, November 18th, 2008

A double-blind, placebo-controlled crucial ponder of LGS patients treated with Banzel as adjunctive remedy showed a 42.5 percent median reduction in frequency of decline attacks, seizures that cause a mortal to mislay consciousness and destruction to the ground, compared with a 1.4 percent median enlargement for placebo-treated patients. Drop attacks are a leading cause of offence in LGS patients.

"People living with LGS stress more remedying options," said Tracy Glauser, MD, Director, Comprehensive Epilepsy Program, Cincinnati Children's Hospital Medical Center, Ohio, and usher investigator in a clinical misery for Banzel. "What's sexy about this muse about is that Banzel was noticeable and non-specifically well tolerated in children with LGS whose seizures were heretofore ungoverned on Other multiple antiepileptic medications." LGS is a Cancer that is keen to the lives of patients and caregivers.

(more...)

Related posts

The SKAMP rating escalade is a set assessment tool Euphemistic pre-owned in laboratory classroom clinical trials to judge attention and behavior. Drug approbation.

Saturday, November 15th, 2008

The immature labeling is based on clinical deliberate over data. The most late study, involving 86 children with ADHD between the ages of six and 12, showed that Focalin Xr provided significant improvements at 30 minutes post-dose compared to placebo in measures of attention, deportment, and erudite productivity. ADHD affects approximately three to six percent of children in the United States, and its symptoms - inattention, hyperactivity and impulsivity - can significantly bearing a child's cleverness to pinpoint and bear in school.

A 2007 Harris size up of 1,001 caregivers of babyish ADHD patients revealed that caregivers were significantly more qualified to reveal that their child's or adolescent's behavior was negatively counterfeit in the matutinal compared to Other periods through the age in 12 out of 16 undistinguished behaviors. These cold behaviors included fall short of of concentration, messiness, interrupting others, flop to full tasks and speaking out of turn. "The 30-minute attack of effect can aide children with ADHD modernize their matinal lettered productivity in school. Focalin Xr also allows them to effectively shift their symptoms for up to 12 hours getting them through college and homework time," said Rafael Muniz, MD, Senior Medical Director, Novartis Pharmaceuticals Corporation.

(more...)

Related posts

Report any extraordinary vaginal bleeding set to rights away while you are using Premarin Vaginal Cream. Drug approbation.

Friday, November 14th, 2008

"This licence is receive news, especially when you estimate that more than one in four untreated postmenopausal Women practice dyspareunia, a symptom of vulvar and vaginal atrophy, which typically does not sink without treatment," says Gloria Bachmann, M.D., Director of the Women's Health Institute at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, N.J. and Chief of the OB/GYN serving at the teaching hospital.

Premarin Vaginal Cream is the initially vaginal estrogen group therapy indicated for the curing of ordinary to rigid dyspareunia due to menopause. A low-volume regimen of Premarin Vaginal Cream can to unpleasant sexual relations due to menopause, fix vaginal tissue, and mirror changes in the vagina that materialize with menopause. The mandate is based on efficacy results from a multicenter clinical swat that included a 12-week randomized, double-blind placebo point of view followed by a 40-week open-label phase. Results from the 12-week aspect showed that both low-dose regimens of Premarin Vaginal Cream (0.5 g circadian [21 days on/7 days off] or twice weekly) significantly improved the dyspareunia amount versus placebo at 12 weeks.

(more...)

Related posts

FDA Grants Clearance for Celera’s ViroSeq HIV. Drug approbation.

Friday, November 14th, 2008

The efficacy of HIV-1 medicament cure is modulated by the modifying toll of the HIV-1 virus during sedative treatment, which can diva to drug stubbornness and consequent therapeutic failure amidst individuals. Studies have found that a significant number of poison treated patients show signs of defences to one or more drugs typically used to survey HIV. The rate of dull resistance among new cases is also increasing.

Up to 15% of treatment naive individuals newly diagnosed with HIV were infected with a derivation that was already immovable to at least one antiretroviral drug. Genotyping is a sequencing-based testing regularity that is routinely employed by laboratories and clinicians throughout the set to learn the genetic composition of the HIV-1 virus. The ViroSeq System consists of an automated DNA sequencing platform, reagents and dedicated software in use to genotype strains of the HIV-1 virus that infect the patient. The procedure targets clear-cut regions of the viral genome that can amplify drug-resistant mutations. ViroSeq's intoxicated throughput processing provides an integrated organized whole from representation concoction to the terminating interpretive denial appear to aid the doctor in drug treatment decisions.

celera

(more...)

Related posts

EKR Therapeutics Broadens Its Ready. Drug approbation.

Friday, November 14th, 2008

These patented 200 ml ready-to-use (RTU) intravenous bags curb 40 mg of the calcium way blocker nicardipine hydrochloride (0.2 mg/ml) in either dextrose or sodium chloride. The licence follows EKR's proclamation on August 1, 2008 that the FDA had approved standard, or distinct (1X), concentration Cardene I.V. RTU bags The 1X preparations consist of 200 ml premixed bags containing 20 mg of nicardipine hydrochloride (0.1 mg/ml) in either dextrose or sodium chloride.

EKR popular that shipments of 1X Cardene I.V. RTU bags have already begun and that the Company is preparing to take possession of orders for the uncharted 2X preparations. The Company further prominent that these premixed intravenous preparations tolerate TJC (previously JCAHO) and ASHP standards to dish out medication in the most inclined to provide form.

(more...)

Related posts

Noven Announces Final FDA Approval of Stavzor for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches. Drug approbation.

Thursday, November 13th, 2008

By visiting , consumers can access additional message on Stavzor and entreaty a Stavzor Easy Save Pharmacy Card that can provender a significant savings off every co-payment. The Stavzor website also explains how the Stavzor Pharmacy Locator Service can aide patients gorge their Stavzor medicine at their preferred pharmacy. In addition, physicians can use the website to solicitation Stavzor samples. Important Product Safety Information about Stavzor Valproate Products should not be administered to patients with hepatic illness or significant hepatic dysfunction.

Hepatic loser resulting in fatalities has occurred in patients receiving valproic acid and its derivatives, customarily during the blue ribbon six months of treatment. Valproate may bring forth teratogenic paraphernalia in the progeny of Women receiving the knock out during pregnancy. Benefits of valproate should be weighed against chance of damage to the fetus in Women of childbearing potential. Cases of life-threatening pancreatitis, some instanter progressing to death, have been reported in both adults and children receiving valproate.

(more...)

Related posts

FDA Approves New Cardene Formulation. Drug approbation.

Tuesday, November 11th, 2008

The RTU formulations significantly heighten the Cardene franchise which has for the most part consisted of sales of Cardene I.V. ampoules.

"We await the convenience and eagerness of the intravenous bags to significantly team and establish upon the exchange name of the Cardene I.V. ampoules," said Howard Weisman, EKR's Chairman & CEO. EKR estimates that over 900,000 patients have been treated with Cardene I.V. since 2003.

(more...)

Related posts

FDA Approves Ranexa for First Line Anti Anginal Use. Drug approbation.

Tuesday, November 11th, 2008

According to the revised labeling, Ranexa is indicated for the healing of confirmed angina and may be worn simply or in grouping with ritual therapies for inveterate angina, such as beta blockers, calcium medium blockers and nitrates, and standard cardio-protective treatments for cardiovascular affliction such as anti-platelet therapy, lipid-lowering therapy, ACE inhibitors and angiotensin receptor blockers. Ranexa may now be reach-me-down as component of an optimal medical psychotherapy regimen for long-lived angina patients, anyway of whether or not they receive a stent or Other medical intervention. Ranexa does not humble kindness rate or Blood Pressure and, dissimilar long acting nitrates, Ranexa can be prescribed for patients compelling spoken erectile dysfunction treatments. "This powerful FDA influence allows the benefits of Ranexa to be extended to more patients.

The reborn labeling obviously describes the substantial proven sanctuary and efficacy of Ranexa for the therapy of chronic angina, the debilitating cardiac Breast Pain that affects more than nine million Americans each year," said Louis G. Lange, CV Therapeutics chairman and ringleader chairman officer. "Ranexa is a very well tolerated poison that can now be considered in the midst the before drugs to be given to patients with habitual angina. Our commercial categorization will actively Zero in on educating new and existing prescribers about these significant redone labeling improvements," Lange added.

(more...)

Related posts

Disclaimer The preceding free contains forward-looking statements that can be identified by words such as “may”, Drug approbation.

Friday, November 7th, 2008

If you round Diovan HCT and have liver problems or lupus, these conditions may get worse. If you exact Diovan HCT take an oath your falsify if you come about any of the following signs of fluid and electrolyte problems: dehydrated mouth, thirst, dearth of energy, weakness, drowsiness, restlessness, confusion, seizures, Muscle vexation or cramps, Muscle fatigue, very frail urine output, presto heartbeat, or nausea or vomiting. Other lesser crap of Diovan, Diovan HCT, Tekturna, or Exforge have by and large been kindly and brief. The most hackneyed side effects with Diovan and Diovan HCT are trouble and dizziness. A inconsequential effect experienced by more patients attractive Tekturna than patients compelling a sugar pill was diarrhea.

Side belongings that occurred more frequently with Exforge than placebo are distension of the hands, ankles, or feet; nasal congestion or upset throat; take charge or chest cold; and dizziness. Please notice well-built prescribing information about Diovan, Diovan HCT, Tekturna or Exforge at or telephone Christine Cascio at 862-778-8026 or. Disclaimer The former rescue contains forward-looking statements that can be identified by shop-talk such as "may", "could", "likely", "suggests", "will", "risk", "confidence", or almost identical expressions, or by evince or implied discussions anenst capacity following revenues from Diovan HCT and Exforge. Such forward-looking statements uncover the bruited about views of the Company apropos future events, and involve known and untold risks, uncertainties and Other factors that may cause solid results with Diovan HCT and Exforge to be basically different from any unborn results, performance or achievements expressed or implied by such statements.

(more...)

Related posts

Important factors that may cause or bestow to such differences subsume whether the Company’s products will abet in the clinical trials process on a opportune basis or at all, Drug approbation.

Friday, November 7th, 2008

The Medicines Company (NASDAQ: MDCO) is focused on advancing the therapy of important circumspection patients through the deliverance of innovative, cost-effective medicines to the worldwide infirmary marketplace. The Company markets Angiomax® (bivalirudin) in the United States and Other countries for use in patients undergoing coronary angioplasty, as well as Cleviprex (clevidipine butyrate) injectable emulsion in the United States for the reduction of Blood persuade when verbal remedial programme is not doable or not desirable. The Company also has one Product, cangrelor, in late-stage development. The Company's website is. Statements contained in this herd publicity release about The Medicines Company that are not purely historical, and All Other statements that are not purely historical, may be deemed to be forward-looking statements for purposes of the whole harbor provisions under The Private Securities Litigation Reform Act of 1995.

Without limiting the foregoing, the words "believes," "anticipates" and "expects" and alike expressions are intended to recognize forward-looking statements. These forward-looking statements embrace known and unrevealed risks and uncertainties that may cause the Company's physical results, levels of activity, interpretation or achievements to be much bizarre from those expressed or implied by these forward-looking statements. Important factors that may cause or donate to such differences embrace whether the Company's Products will lend in the clinical trials alter on a favourable heart or at All, whether clinical burr under the saddle results will assure submittal of applications for regulatory approval, whether the Company will be able to be established regulatory approvals, whether physicians, patients and Other pitch decision-makers will reconcile oneself to clinical hassle results, and such Other factors as are set forth in the jeopardy factors minute from heyday to ease in the Company's cyclic reports and registration statements filed with the Securities and Exchange Commission including, without limitation, the endanger factors complete in the Company's Quarterly Report on Form 10-Q filed on May 12, 2008, which are incorporated herein by reference.

(more...)

Related posts